QUALITY AS THE
WE BASE OUR
From Ojer Pharma we focused all our efforts in the research and development of new dermatological products, while we seek to optimize our resources through an adequate R&D management based on the standards UNE 166002 (I+D+I management). Thus, we are able to:
- Manage the R&D more efficiently and effectively.
- Consolidate the R&D activities as a competitive differentiating factor.
- Improve the organization communication between the departments and people
involved in the R&D process.
- Improve the exploitation of the results from the R&D.
The innovation management faces the pharmaceutical development as a whole, considering all aspects
from the technological surveillance to the authorization of the product on the market. Innovation
management consists of several parts shown in the graphic below:
Ojer Pharma collaborates closely with two of the most nationally prestigious universities in the biomedical sector, as well as with their research centers and developing structures: Universidad de Navarra and University of Barcelona
The University of Barcelona (UB) is a public university located in the city of Barcelona (Catalonia). With over 500 years of history, the UB has 19 faculties and university schools, 8 university institutes and several associated centers that contribute to the creation, transfer and dissemination of culture and scientific, technical and professional knowledge. In 1996, the UB, through the Pharmacy Faculty, and managed by the Fundación Bosch I Gimpera (FBIG), set up the Service of Development of Medicines (SDM) ) to make the necessary collaboration between the university and the pharmaceutical industry possible. The SDM supplies technical, scientific and research services and projects, to develop medical devices and medicinal products for both human and animal use. For this purpose, the SDM has modern facilities of 460m2 with manufacturing area, quality assurance, quality control and quality guarantee.
GO TO UNIVERSITY WEB